
Philadelphia 76ers · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 32.9 | 25.7 | 4.3 | 3.7 | 33.7 | 1.0 | 0.0 | 2.0 | 6.7 | 12.0 |
| 55.6% |
| 2.7 |
| 8.3 |
| 32.0% |
| 4.3 |
| 4.7 |
| 92.9% |
| Last 5 | 5 | 34.3 | 23.0 | 3.4 | 4.0 | 30.4 | 0.8 | 0.0 | 2.4 | 6.2 | 12.0 | 51.7% | 2.2 | 6.8 | 32.4% | 4.0 | 4.6 | 87.0% |
| Last 10 | 10 | 36.5 | 24.4 | 4.1 | 5.9 | 34.4 | 1.0 | 0.5 | 2.7 | 6.9 | 12.3 | 56.1% | 2.1 | 6.4 | 32.8% | 4.3 | 4.8 | 89.6% |
| Last 20 | 20 | 35.9 | 26.9 | 4.0 | 5.8 | 36.7 | 1.5 | 0.8 | 2.5 | 6.9 | 13.5 | 51.3% | 2.5 | 7.8 | 32.5% | 5.5 | 6.1 | 90.2% |
| Season | 70 | 38.0 | 28.3 | 4.1 | 6.6 | 39.0 | 1.9 | 0.8 | 2.4 | 6.8 | 12.9 | 52.5% | 3.1 | 8.6 | 36.7% | 5.3 | 6.0 | 89.2% |
high usage, high on-ball creation, high assist rate, low rim finishing off the ball
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | PHI vs. MIL | W | 27.0 | 21 | 2 | 1 | 1 | 0 | 3 | 8 | 13 | 61.5% | 2 | 5 | 40.0% | 3 | 3 | 100.0% | 13.0 |
| 2026-04-10 | PHI @ IND | W | 38.5 | 32 | 8 | 5 | 2 | 0 | 1 | 11 | 28 | 39.3% | 1 | 10 | 10.0% | 9 | 10 | 90.0% | 18.0 |
| 2026-04-09 | PHI @ HOU | L | 33.3 | 24 | 3 | 5 | 0 | 0 | 2 | 9 | 20 | 45.0% | 5 | 10 | 50.0% | 1 | 1 | 100.0% | -18.0 |
| 2026-04-06 | PHI @ SAS | L | 39.6 | 15 | 3 | 8 | 0 | 0 | 4 | 6 | 16 | 37.5% | 1 | 4 | 25.0% | 2 | 2 | 100.0% | -15.0 |
| 2026-04-04 | PHI vs. DET | L | 33.2 | 23 | 1 | 1 | 1 | 0 | 2 | 8 | 17 | 47.1% | 2 | 5 | 40.0% | 5 | 7 | 71.4% | -27.0 |
| 2026-04-03 | PHI vs. MIN | W | 34.9 | 21 | 6 | 8 | 0 | 2 | 3 | 7 | 13 | 53.8% | 1 | 3 | 33.3% | 6 | 6 | 100.0% | 14.0 |
| 2026-04-01 | PHI @ WAS | W | 34.0 | 28 | 2 | 9 | 1 | 0 | 2 | 12 | 20 | 60.0% | 1 | 5 | 20.0% | 3 | 4 | 75.0% | 28.0 |
| 2026-03-30 | PHI @ MIA | L | 43.9 | 23 | 7 | 9 | 0 | 2 | 2 | 7 | 20 | 35.0% | 2 | 9 | 22.2% | 7 | 7 | 100.0% | 1.0 |
| 2026-03-28 | PHI @ CHA | W | 43.0 | 26 | 7 | 8 | 1 | 1 | 3 | 10 | 18 | 55.6% | 3 | 6 | 50.0% | 3 | 4 | 75.0% | 13.0 |
| 2026-03-07 | PHI @ ATL | L | 37.8 | 31 | 2 | 5 | 4 | 0 | 5 | 12 | 22 | 54.5% | 3 | 7 | 42.9% | 4 | 4 | 100.0% | -10.0 |
| 2026-03-04 | PHI vs. UTA | W | 37.9 | 25 | 2 | 6 | 1 | 3 | 1 | 8 | 22 | 36.4% | 2 | 10 | 20.0% | 7 | 7 | 100.0% | 8.0 |
| 2026-03-03 | PHI vs. SAS | L | 25.1 | 21 | 8 | 2 | 1 | 1 | 2 | 8 | 19 | 42.1% | 2 | 6 | 33.3% | 3 | 4 | 75.0% | -36.0 |
| 2026-03-01 | PHI @ BOS | L | 43.3 | 33 | 3 | 6 | 1 | 2 | 0 | 12 | 34 | 35.3% | 4 | 11 | 36.4% | 5 | 6 | 83.3% | -9.0 |
| 2026-02-26 | PHI vs. MIA | W | 37.8 | 28 | 4 | 11 | 5 | 1 | 1 | 9 | 26 | 34.6% | 5 | 12 | 41.7% | 5 | 5 | 100.0% | 6.0 |
| 2026-02-24 | PHI @ IND | W | 33.6 | 32 | 9 | 8 | 2 | 1 | 2 | 10 | 22 | 45.5% | 2 | 8 | 25.0% | 10 | 10 | 100.0% | 21.0 |
| 2026-02-22 | PHI @ MIN | W | 35.5 | 39 | 3 | 8 | 2 | 1 | 5 | 16 | 28 | 57.1% | 4 | 7 | 57.1% | 3 | 5 | 60.0% | 21.0 |
| 2026-02-21 | PHI @ NOP | L | 36.2 | 27 | 3 | 7 | 5 | 0 | 5 | 9 | 23 | 39.1% | 2 | 11 | 18.2% | 7 | 8 | 87.5% | -4.0 |
| 2026-02-19 | PHI vs. ATL | L | 38.8 | 28 | 3 | 3 | 1 | 1 | 2 | 8 | 23 | 34.8% | 4 | 11 | 36.4% | 8 | 8 | 100.0% | -7.0 |
| 2026-02-11 | PHI vs. NYK | L | 32.1 | 32 | 2 | 2 | 1 | 0 | 1 | 9 | 21 | 42.9% | 3 | 8 | 37.5% | 11 | 13 | 84.6% | -26.0 |
| 2026-02-09 | PHI @ POR | L | 32.5 | 30 | 1 | 4 | 1 | 0 | 4 | 10 | 21 | 47.6% | 2 | 9 | 22.2% | 8 | 8 | 100.0% | -22.0 |
| 2026-02-07 | PHI @ PHX | W | 39.8 | 29 | 9 | 6 | 1 | 0 | 3 | 8 | 21 | 38.1% | 3 | 10 | 30.0% | 10 | 11 | 90.9% | 14.0 |
| 2026-02-05 | PHI @ LAL | L | 37.4 | 26 | 0 | 13 | 4 | 0 | 4 | 11 | 22 | 50.0% | 1 | 9 | 11.1% | 3 | 4 | 75.0% | 8.0 |
| 2026-02-03 | PHI @ GSW | W | 33.7 | 14 | 4 | 3 | 2 | 0 | 1 | 3 | 9 | 33.3% | 1 | 5 | 20.0% | 7 | 7 | 100.0% | 14.0 |
| 2026-02-02 | PHI @ LAC | W | 35.9 | 29 | 5 | 6 | 3 | 0 | 1 | 9 | 18 | 50.0% | 7 | 14 | 50.0% | 4 | 4 | 100.0% | 22.0 |
| 2026-01-31 | PHI vs. NOP | W | 35.3 | 18 | 5 | 8 | 1 | 0 | 1 | 7 | 18 | 38.9% | 4 | 9 | 44.4% | 0 | 0 | 0.0% | 5.0 |
| 2026-01-29 | PHI vs. SAC | W | 40.6 | 40 | 4 | 8 | 1 | 0 | 2 | 12 | 18 | 66.7% | 4 | 9 | 44.4% | 12 | 13 | 92.3% | 8.0 |
| 2026-01-27 | PHI vs. MIL | W | 36.0 | 22 | 3 | 9 | 0 | 0 | 1 | 9 | 19 | 47.4% | 2 | 8 | 25.0% | 2 | 2 | 100.0% | 5.0 |
| 2026-01-26 | PHI @ CHA | L | 25.3 | 6 | 2 | 7 | 0 | 0 | 3 | 3 | 12 | 25.0% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -36.0 |
| 2026-01-24 | PHI vs. NYK | L | 38.1 | 22 | 3 | 6 | 2 | 1 | 3 | 8 | 15 | 53.3% | 3 | 7 | 42.9% | 3 | 3 | 100.0% | -7.0 |
| 2026-01-22 | PHI vs. HOU | W | 42.7 | 36 | 2 | 10 | 3 | 0 | 3 | 15 | 28 | 53.6% | 2 | 10 | 20.0% | 4 | 4 | 100.0% | 8.0 |
| 2026-01-20 | PHI vs. PHX | L | 42.7 | 20 | 2 | 7 | 3 | 1 | 2 | 7 | 25 | 28.0% | 2 | 8 | 25.0% | 4 | 5 | 80.0% | 3.0 |
| 2026-01-19 | PHI vs. IND | W | 40.2 | 29 | 4 | 8 | 8 | 1 | 2 | 12 | 24 | 50.0% | 1 | 4 | 25.0% | 4 | 4 | 100.0% | 16.0 |
| 2026-01-16 | PHI vs. CLE | L | 38.7 | 22 | 5 | 9 | 5 | 2 | 2 | 9 | 23 | 39.1% | 2 | 8 | 25.0% | 2 | 2 | 100.0% | -4.0 |
| 2026-01-14 | PHI vs. CLE | L | 31.2 | 14 | 2 | 4 | 0 | 2 | 0 | 5 | 16 | 31.3% | 2 | 8 | 25.0% | 2 | 2 | 100.0% | -22.0 |
| 2026-01-12 | PHI @ TOR | W | 34.9 | 33 | 4 | 2 | 1 | 0 | 1 | 10 | 16 | 62.5% | 6 | 9 | 66.7% | 7 | 7 | 100.0% | 13.0 |
| 2026-01-11 | PHI @ TOR | L | 44.5 | 38 | 4 | 5 | 2 | 2 | 5 | 13 | 27 | 48.1% | 2 | 7 | 28.6% | 10 | 12 | 83.3% | 17.0 |
| 2026-01-09 | PHI @ ORL | W | 37.9 | 29 | 1 | 1 | 3 | 0 | 1 | 10 | 22 | 45.5% | 3 | 8 | 37.5% | 6 | 6 | 100.0% | 7.0 |
| 2026-01-07 | PHI vs. WAS | W | 28.4 | 22 | 3 | 8 | 2 | 1 | 2 | 9 | 15 | 60.0% | 4 | 10 | 40.0% | 0 | 1 | 0.0% | 20.0 |
| 2026-01-05 | PHI vs. DEN | L | 45.6 | 28 | 6 | 6 | 4 | 2 | 1 | 10 | 22 | 45.5% | 4 | 9 | 44.4% | 4 | 6 | 66.7% | -1.0 |
| 2026-01-03 | PHI @ NYK | W | 37.4 | 36 | 8 | 4 | 1 | 2 | 4 | 14 | 22 | 63.6% | 6 | 9 | 66.7% | 2 | 4 | 50.0% | 6.0 |
| 2026-01-01 | PHI @ DAL | W | 42.4 | 34 | 8 | 10 | 2 | 2 | 3 | 14 | 24 | 58.3% | 4 | 10 | 40.0% | 2 | 2 | 100.0% | 18.0 |
| 2025-12-30 | PHI @ MEM | W | 43.1 | 34 | 4 | 12 | 2 | 0 | 0 | 13 | 21 | 61.9% | 4 | 7 | 57.1% | 4 | 5 | 80.0% | 2.0 |
| 2025-12-28 | PHI @ OKC | L | 36.4 | 28 | 2 | 5 | 4 | 0 | 5 | 10 | 18 | 55.6% | 2 | 7 | 28.6% | 6 | 7 | 85.7% | -22.0 |
| 2025-12-26 | PHI @ CHI | L | 40.4 | 27 | 5 | 8 | 0 | 2 | 2 | 9 | 24 | 37.5% | 5 | 11 | 45.5% | 4 | 4 | 100.0% | 0.0 |
| 2025-12-23 | PHI vs. BKN | L | 39.3 | 13 | 3 | 2 | 4 | 0 | 4 | 3 | 14 | 21.4% | 0 | 5 | 0.0% | 7 | 7 | 100.0% | -19.0 |
| 2025-12-20 | PHI vs. DAL | W | 40.7 | 38 | 2 | 4 | 1 | 1 | 0 | 15 | 31 | 48.4% | 5 | 11 | 45.5% | 3 | 3 | 100.0% | 0.0 |
| 2025-12-19 | PHI @ NYK | W | 37.8 | 30 | 2 | 9 | 1 | 0 | 3 | 11 | 24 | 45.8% | 6 | 12 | 50.0% | 2 | 2 | 100.0% | 7.0 |
| 2025-12-07 | PHI vs. LAL | L | 38.8 | 28 | 7 | 9 | 2 | 2 | 4 | 11 | 24 | 45.8% | 5 | 8 | 62.5% | 1 | 2 | 50.0% | -9.0 |
| 2025-12-05 | PHI @ MIL | W | 36.8 | 12 | 4 | 4 | 4 | 1 | 2 | 5 | 14 | 35.7% | 0 | 3 | 0.0% | 2 | 2 | 100.0% | 16.0 |
| 2025-12-04 | PHI vs. GSW | W | 39.7 | 35 | 3 | 2 | 2 | 1 | 3 | 13 | 27 | 48.1% | 4 | 10 | 40.0% | 5 | 5 | 100.0% | 7.0 |
| 2025-12-02 | PHI vs. WAS | W | 28.8 | 35 | 4 | 6 | 4 | 1 | 0 | 13 | 26 | 50.0% | 4 | 9 | 44.4% | 5 | 5 | 100.0% | 23.0 |
| 2025-11-30 | PHI vs. ATL | L | 52.3 | 44 | 7 | 9 | 0 | 1 | 6 | 14 | 31 | 45.2% | 2 | 13 | 15.4% | 14 | 17 | 82.4% | -8.0 |
| 2025-11-28 | PHI @ BKN | W | 41.7 | 22 | 9 | 7 | 1 | 1 | 1 | 7 | 16 | 43.8% | 2 | 8 | 25.0% | 6 | 6 | 100.0% | 8.0 |
| 2025-11-25 | PHI vs. ORL | L | 32.0 | 20 | 1 | 4 | 1 | 0 | 1 | 7 | 15 | 46.7% | 1 | 5 | 20.0% | 5 | 6 | 83.3% | -30.0 |
| 2025-11-23 | PHI vs. MIA | L | 36.3 | 27 | 3 | 6 | 2 | 0 | 3 | 10 | 23 | 43.5% | 5 | 14 | 35.7% | 2 | 2 | 100.0% | -14.0 |
| 2025-11-20 | PHI @ MIL | W | 46.6 | 54 | 5 | 9 | 3 | 3 | 5 | 18 | 30 | 60.0% | 6 | 15 | 40.0% | 12 | 14 | 85.7% | 18.0 |
| 2025-11-19 | PHI vs. TOR | L | 38.5 | 24 | 2 | 9 | 3 | 1 | 3 | 8 | 14 | 57.1% | 5 | 9 | 55.6% | 3 | 4 | 75.0% | -2.0 |
| 2025-11-17 | PHI vs. LAC | W | 40.9 | 39 | 3 | 6 | 1 | 0 | 4 | 13 | 27 | 48.1% | 4 | 11 | 36.4% | 9 | 10 | 90.0% | 4.0 |
| 2025-11-14 | PHI @ DET | L | 39.6 | 31 | 7 | 3 | 4 | 0 | 3 | 13 | 31 | 41.9% | 2 | 11 | 18.2% | 3 | 3 | 100.0% | -10.0 |
| 2025-11-11 | PHI vs. BOS | W | 33.6 | 21 | 5 | 9 | 1 | 0 | 0 | 5 | 17 | 29.4% | 3 | 6 | 50.0% | 8 | 8 | 100.0% | -6.0 |
| 2025-11-09 | PHI vs. DET | L | 38.1 | 33 | 4 | 7 | 2 | 0 | 3 | 10 | 26 | 38.5% | 4 | 12 | 33.3% | 9 | 9 | 100.0% | -6.0 |
| 2025-11-08 | PHI vs. TOR | W | 42.6 | 31 | 4 | 7 | 1 | 2 | 1 | 12 | 24 | 50.0% | 3 | 10 | 30.0% | 4 | 5 | 80.0% | 21.0 |
| 2025-11-05 | PHI @ CLE | L | 36.4 | 27 | 7 | 9 | 1 | 0 | 5 | 10 | 20 | 50.0% | 2 | 5 | 40.0% | 5 | 8 | 62.5% | -7.0 |
| 2025-11-04 | PHI @ CHI | L | 39.3 | 39 | 5 | 5 | 1 | 3 | 4 | 14 | 26 | 53.8% | 6 | 10 | 60.0% | 5 | 5 | 100.0% | 3.0 |
| 2025-11-02 | PHI @ BKN | W | 38.8 | 26 | 6 | 7 | 1 | 0 | 1 | 9 | 19 | 47.4% | 4 | 9 | 44.4% | 4 | 4 | 100.0% | 21.0 |
| 2025-10-31 | PHI vs. BOS | L | 43.6 | 26 | 8 | 14 | 2 | 2 | 5 | 8 | 16 | 50.0% | 4 | 9 | 44.4% | 6 | 7 | 85.7% | 10.0 |
| 2025-10-28 | PHI @ WAS | W | 47.4 | 39 | 3 | 10 | 1 | 1 | 4 | 11 | 25 | 44.0% | 3 | 9 | 33.3% | 14 | 16 | 87.5% | 3.0 |
| 2025-10-27 | PHI vs. ORL | W | 41.5 | 43 | 4 | 8 | 1 | 0 | 1 | 15 | 32 | 46.9% | 4 | 11 | 36.4% | 9 | 10 | 90.0% | 14.0 |
| 2025-10-25 | PHI vs. CHA | W | 41.7 | 28 | 6 | 9 | 0 | 1 | 2 | 7 | 20 | 35.0% | 4 | 9 | 44.4% | 10 | 12 | 83.3% | 3.0 |
| 2025-10-22 | PHI @ BOS | W | 41.4 | 40 | 2 | 6 | 2 | 1 | 1 | 13 | 24 | 54.2% | 7 | 9 | 77.8% | 7 | 8 | 87.5% | 3.0 |